Explore innovative nutritional and microbial strategies for effectively treating acne, alopecia, and atopic dermatitis.

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Researchers recently identified five extrapulmonary treatable traits in asthma that are clinically relevant and have a clear ...

It is time to set the record straight and uncover the truth as Atopic Dermatitis is not just a skin issue; it can impact ...

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis with upadacitinib is safe and effective through 76 weeks.

Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heightened ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

Posters at AMCP Nexus analyzed the burden of flares on patients with atopic dermatitis (AD) and the impact initiating ...

Positive results were announced from the ECZTEND extension study of Adbry in atopic dermatitis who took part in a previous parent trial.